U.S.: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2024

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the U.S.

The U.S. human and animal blood market rose slightly to $X in 2023, with an increase of X% against the previous year. Overall, consumption, however, recorded a perceptible setback. Human and animal blood consumption peaked at $X in 2012; however, from 2013 to 2023, consumption stood at a somewhat lower figure.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the U.S.

In value terms, human and animal blood production reached $X in 2023. Over the period under review, production, however, showed a relatively flat trend pattern. The pace of growth was the most pronounced in 2021 with an increase of X%. Human and animal blood production peaked at $X in 2013; however, from 2014 to 2023, production failed to regain momentum.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from the U.S.

In 2023, overseas shipments of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses decreased by X% to X tons, falling for the second consecutive year after two years of growth. Overall, exports, however, posted a notable expansion. The most prominent rate of growth was recorded in 2017 when exports increased by X% against the previous year. The exports peaked at X tons in 2021; however, from 2022 to 2023, the exports failed to regain momentum.

In value terms, human and animal blood exports shrank rapidly to $X in 2023. In general, exports, however, posted resilient growth. The pace of growth was the most pronounced in 2017 when exports increased by X%. Over the period under review, the exports hit record highs at $X in 2021; however, from 2022 to 2023, the exports remained at a lower figure.

Exports by Country

Canada (X tons), Ireland (X tons) and Vietnam (X tons) were the main destinations of human and animal blood exports from the United States, with a combined X% share of total exports.

From 2012 to 2023, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Vietnam (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, the largest markets for human and animal blood exported from the United States were the UK ($X), Ireland ($X) and Japan ($X), with a combined X% share of total exports. Germany, Canada, China, Belgium, Vietnam, Mexico, Brazil, Taiwan (Chinese), Ecuador and Thailand lagged somewhat behind, together accounting for a further X%.

Among the main countries of destination, Vietnam, with a CAGR of X%, recorded the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2023, the average human and animal blood export price amounted to $X per ton, increasing by X% against the previous year. Overall, the export price showed a resilient increase. The most prominent rate of growth was recorded in 2018 an increase of X%. Over the period under review, the average export prices hit record highs at $X per ton in 2021; however, from 2022 to 2023, the export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Germany ($X per ton), while the average price for exports to Vietnam ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to Brazil (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into the U.S.

In 2023, purchases abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses decreased by X% to X tons, falling for the third consecutive year after three years of growth. In general, imports continue to indicate a perceptible shrinkage. The pace of growth was the most pronounced in 2014 with an increase of X%. As a result, imports attained the peak of X tons. From 2015 to 2023, the growth of imports remained at a lower figure.

In value terms, human and animal blood imports shrank notably to $X in 2023. Over the period under review, imports saw a abrupt slump. The most prominent rate of growth was recorded in 2014 when imports increased by X%. Imports peaked at $X in 2018; however, from 2019 to 2023, imports stood at a somewhat lower figure.

Imports by Country

Germany (X tons), China (X tons) and the UK (X tons) were the main suppliers of human and animal blood imports to the United States, with a combined X% share of total imports. Italy, Denmark, Spain, India, Canada, Japan, Switzerland, Argentina, France and Australia lagged somewhat behind, together accounting for a further X%.

From 2012 to 2023, the biggest increases were recorded for Spain (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the UK ($X) constituted the largest supplier of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses to the United States, comprising X% of total imports. The second position in the ranking was held by Germany ($X), with an X% share of total imports. It was followed by Switzerland, with a X% share.

From 2012 to 2023, the average annual growth rate of value from the UK stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (X% per year) and Switzerland (X% per year).

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2023, declining by X% against the previous year. Overall, the import price faced a deep slump. The pace of growth was the most pronounced in 2017 when the average import price increased by X% against the previous year. The import price peaked at $X per ton in 2012; however, from 2013 to 2023, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was the UK ($X,000 per ton), while the price for Argentina ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Switzerland (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform